DiaSorin S.p.A. (OTCMKTS:DSRLF) Sees Significant Growth in Short Interest

DiaSorin S.p.A. (OTCMKTS:DSRLF) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 218,900 shares, an increase of 58.9% from the February 13th total of 137,800 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,189.0 days. Currently, 0.4% of the company’s stock are short sold.

DiaSorin Stock Performance

Shares of DiaSorin stock remained flat at $109.60 during trading on Friday. The business’s 50-day simple moving average is $104.96 and its 200 day simple moving average is $104.08. DiaSorin has a 12-month low of $100.26 and a 12-month high of $109.60.

Wall Street Analysts Forecast Growth

Separately, UBS Group cut shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.